Yahoo Finance1 天
Cantargia Presents Promising Preclinical Results on Nadunolimab With Antibody-Drug ...
In addition, these factors also stimulate inflammation-related damage to the nervous system, contributing to ...
McKnight's Long-Term Care News5 天
Report: Parkinson’s, Alzheimer’s drug costs soared over nearly decade; MS meds rose most
People with multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, and that amount soared to $2,378 annually in 2021, according to a new study. The study  examined the ...
Armed robbery in Revesby5 天
Neurologic Drug Costs Soar for Patients
Out-of-pocket costs continue to increase for patients who must buy commonly prescribed drugs to treat these five neurological ...
Out-of-pocket costs for MS, Parkinson's, Alzheimer's meds keep rising
Out-of-pocket costs for drugs for neurologic diseases such as MS, Parkinson's and Alzheimer's disease are climbing sharply, ...
healthday6 天
Costs for MS, Parkinson's and Alzheimer's Meds Keep Rising
A person battling multiple sclerosis spent an average of $750 in out-of-pocket fees on medicines in 2012, but by 202 ...
Too Old to Operate6 天
Generic Medications Can Keep OOP Costs Down for Neurological Conditions
Generic medications reduce the out-of-pocket (OOP) costs for common neurological conditions, apart from multiple sclerosis, ...
Armed robbery in Revesby6 天
Drug Costs Surge for Neurological Diseases
The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), ...
Costs still on the rise for drugs for neurological diseases, finds study
The amount of money people pay out-of-pocket for branded drugs to treat neurological diseases like multiple sclerosis (MS), ...